Aktis Oncology, Inc. (AKTS)

Insiders sold $3.2M in the past 12 months, 8.0% under disclosed plans; their starting stakes can't be measured from the filings. Why

Latest filing: Filed Sep 24 for a sale on Sep 23. Akos Czibere sold 12K shares ($259K) under a disclosed plan. Filing